48,790
edits
Line 1: | Line 1: | ||
{{ Infobox diagnosis | |||
| Name = {{PAGENAME}} | |||
| Image = | |||
| Width = | |||
| Caption = | |||
| Synonyms = suspicious for prostate carcinoma | |||
| Micro = morphology of prostate carcinoma but less than 6 glands (major criteria: abnormal architecture (increased gland density, usu. small circular glands, "infiltrative growth" pattern), basal cells lost, cytological abnormalities (nuclear enlargement, nucleoli); minor criteria: nuclear hyperchromasia, wispy blue mucin, pink amorphous secretions, intraluminal crystalloid, amphophilic cytoplasm, adjacent HGPIN, mitoses) | |||
| Subtypes = | |||
| LMDDx = [[prostate adenocarcinoma]], benign prostate | |||
| Stains = | |||
| IHC = AMACR +ve, CK34betaE12 -ve, p63 -ve, PSA +ve | |||
| EM = | |||
| Molecular = | |||
| IF = | |||
| Gross = | |||
| Grossing = | |||
| Site = [[prostate gland]] | |||
| Assdx = | |||
| Syndromes = | |||
| Clinicalhx = | |||
| Signs = | |||
| Symptoms = | |||
| Prevalence = ~3-5% of prostate biopsies | |||
| Bloodwork = +/-PSA elevated | |||
| Rads = | |||
| Endoscopy = | |||
| Prognosis = increased risk of prostate carcinoma | |||
| Other = [[waffle diagnosis]] - used only on biopsy | |||
| ClinDDx = | |||
| Tx = re-biopsy, close follow-up | |||
}} | |||
'''Atypical small acinar proliferation''', abbreviated ''ASAP'', is a small number of [[prostate gland|prostate glands]] that are abnormal and suspicious for [[prostate carcinoma|carcinoma]]. | '''Atypical small acinar proliferation''', abbreviated ''ASAP'', is a small number of [[prostate gland|prostate glands]] that are abnormal and suspicious for [[prostate carcinoma|carcinoma]]. | ||
It is also known as '''suspicious for carcinoma'''.<ref>THvdK. 19 June 2010.</ref> ASAP is preferred as it does not contain the word ''carcinoma'' and, thus, cannot be misread as ''carcinoma'', i.e. positive for malignancy. | It is also known as '''suspicious for carcinoma'''.<ref name=THvdK>THvdK. 19 June 2010.</ref> ASAP is preferred as it does not contain the word ''carcinoma'' and, thus, cannot be misread as ''carcinoma'', i.e. positive for malignancy. | ||
==General== | ==General== | ||
Line 7: | Line 38: | ||
**Analogous to ''[[ASCUS]]'' on a pap test. | **Analogous to ''[[ASCUS]]'' on a pap test. | ||
*ASAP should be used sparingly. | *ASAP should be used sparingly. | ||
**One benchmark is < 3-5% of biopsies.<ref>THvdK. 19 June 2010.</ref> | **One benchmark is < 3-5% of biopsies.<ref name=THvdK>THvdK. 19 June 2010.</ref> | ||
*Never diagnosed on excision, i.e. prostatectomy specimen. | *Never diagnosed on excision, i.e. prostatectomy specimen. | ||
===Association with adenocarcinoma=== | ===Association with adenocarcinoma=== | ||
*On subsequent | *On a subsequent biopsy the chance of finding [[adenocarcinoma]] is approximately 40%; this is higher than if there is [[high-grade prostatic intraepithelial neoplasia]] (HGPIN).<ref name=pmid18568243>{{cite journal |author=Leite KR, Camara-Lopes LH, Cury J, Dall'oglio MF, Sañudo A, Srougi M |title=Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy |journal=Clinics |volume=63 |issue=3 |pages=339–42 |year=2008 |month=June |pmid=18568243 |doi= |url=http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322008000300009&lng=en&nrm=iso&tlng=en}}</ref> | ||
===Management=== | ===Management=== | ||
*ASAP is considered an indication for re-biopsy;<ref>{{cite journal |author=Bostwick DG, Meiers I |title=Atypical small acinar proliferation in the prostate: clinical significance in 2006 |journal=Arch. Pathol. Lab. Med. |volume=130 |issue=7 |pages=952–7 |year=2006 |month=July |pmid=16831049 |doi= |url=http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=130&page=952}}</ref> in one | *ASAP is generally considered an indication for re-biopsy;<ref name=pmid16831049>{{cite journal |author=Bostwick DG, Meiers I |title=Atypical small acinar proliferation in the prostate: clinical significance in 2006 |journal=Arch. Pathol. Lab. Med. |volume=130 |issue=7 |pages=952–7 |year=2006 |month=July |pmid=16831049 |doi= |url=http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=130&page=952}}</ref> in one study<ref name=pmid15223967>{{cite journal |author=Rubin MA, Bismar TA, Curtis S, Montie JE |title=Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients? |journal=Am. J. Surg. Pathol. |volume=28 |issue=7 |pages=946–52 |year=2004 |month=July |pmid=15223967 |doi= |url=}}</ref> 41/42 (~98%) of urologists considered it a sufficient reason to re-biopsy. | ||
==Microscopic== | ==Microscopic== | ||
Line 33: | Line 64: | ||
==IHC== | ==IHC== | ||
Usually stains like cancer: | Usually stains like cancer: | ||
*AMACR +ve. | *AMACR +ve. | ||
*CK34betaE12 -ve. | *CK34betaE12 -ve. | ||
*p63 -ve. | *p63 -ve. | ||
Note: | |||
*Generally ''not'' contributory. | |||
==Sign out== | |||
<pre> | |||
K. PROSTATE, LEFT LATERAL INTERIOR, BIOPSY: | |||
- ATYPICAL SMALL ACINAR PROLIFERATION. | |||
</pre> | |||
==See also== | ==See also== |
edits